papillon-lefevre disease/carbohydrate

Once participants have consented to be screened, they will come to the lab for a medical screening. If the medical screening is satisfactory, all participants will be asked to undergo a one-week pre-study standardization period. Participants will be asked to maintain their normal dietary and

A total of 22 healthy and regularly active physical-education male students from various sports disciplines volunteered to participate in this study. Potential participants were initially screened through telephone interviews based on the inclusion criteria: 18-40 years of age, BMI less than 25

The present study will be performed as a 6-week randomized fully controlled feeding study, which will address the effect of the hypo-energetic CRHP diet compared with the hypo-energetic CD diet with the macronutrient composition currently recommended to patients with T2D combined with a caloric

Prior to the visit, participants will be issued with a participant information sheet to inform of the procedure and study requirements,then undergo initial screening via email or telephone to ascertain suitability to participate. If interested parties wish to participate, then an invitation for a

This study will utilize a randomized, double-blind, cross-over design, comparing acute ingestion of the mixed flavonoid supplement (MF) compared to placebo control (PC) in healthy, non-obese, pre-menopausal women. The study will consist of two 24-hour study periods spent in the recently renovated

A randomized, double-blind cross-over exercise trial was conducted with 14 runners on Utah State University campus. This population of 14 runners was selected from a larger population of 20 that was recruited to complete two initial trials. In two preliminary visits, the parameters necessary for

It is estimated that in 2050 approximately 40-50% of the adult population worldwide will be overweight/obese (BMI > 25/30 kg/m2), with 10-20% of them developing insulin resistance resulting in metabolic syndrome and type-2 diabetes (T2D). T2D is forecast to become the 7th leading cause of death

- Familiarisation screening visit - (Visit 1) Before participating in the study, all participants will visit the exercise laboratory for a familiarisation and screening visit where they will be shown the designated experimental area, provide written informed consent and have various measurements

The study will be performed as a randomized 12 weeks controlled, cross-over trial, which will address the effects on T2D of an isoenergetic low carbohydrate diet (carbohydrate 30 E%, protein 30 E%, fat 40 E%) compared to an isoenergetic control diet (carbohydrate 50 E%, protein 17 E%, fat 33 E%)

"Ground zero" for the DAWL study will be the University of Guelph Body Composition and Metabolism Lab (www.uoguelph.ca/bodycomp), under the direction of the PI. Sample Size. The investigators plan to complete data collection on a total of 46 women. This sample size is based on an anticipated total